Corcept Therapeutics (CORT) PT Raised to $76 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Joon Lee raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $76.00 (from $65.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
